Skip to main content

Displaying 1 - 20 of 501

Vyera Pharmaceuticals, LLC

The Federal Trade Commission and a group of seven state enforcers filed a complaint in federal district court against Vyera Pharmaceuticals, LLC, alleging an elaborate anticompetitive scheme to preserve a monopoly for the life-saving drug, Daraprim. The Commission vote to issue the complaint was 5-0. The complaint was filed on Jan. 27, 2020, in the U.S. District Court for the Southern District of New York. In a Jan. 14, 2022 ruling, U.S. District Court Judge Denise Cote found Shkreli’s conduct “egregious, deliberate, repetitive, long-running, and ultimately dangerous.” Judge Cote banned Shkreli for life from the pharmaceutical industry.

On January 23, 2024, the U.S. Court of Appeals for the Second Circuit affirmed the U.S. District Court for the Southern District of New York’s ruling.

On October 13, 2026, the FTC and seven states asked a federal judge to hold “Pharma Bro” Martin Shkreli in contempt based on their allegations that he flagrantly and repeatedly violated a 2022 court order that banned him from the pharmaceutical industry.

Type of Action
Federal
Last Updated
FTC Matter/File Number
161 0001
Case Status
Pending

Deere & Company, FTC v.

On July 8, 2026, the FTC, along with five states, secured an important settlement in an antitrust lawsuit against farm equipment manufacturer Deere & Company that will ensure farmers can enjoy the right to repair their own John Deere tractors and farm equipment.

Type of Action
Federal
Last Updated
FTC Matter/File Number
211 0191
Case Status
Pending

Made in USA Rule

Rule Updated Date
Under the rule, marketers making unqualified Made in USA claims on labels should be able to prove that their products are “all or virtually all” made in the United States.